Market Scope

Trusted Global Partner of Industry and Medical Professionals for Ophthalmic Market Research, Primary Research, Independent Perspective, & Objective Analysis

Choose Your Experience

Over 500 Clients, Large & Small from Around the World, Trust Market Scope Data & Analysis

Latest Market Reports

Market Scope's industry reports are meticulously prepared by a dedicated team of in-house consultants/analysts with over 100 years of collective experience.

Latest Industry News & Trends

7/10/2026
BreakingCataractDealsIOLPremiumPresbyopiaSurgical
Alcon and RxSight to Collaborate on Developing Adjustable PC-IOLs
Alcon and RxSight to Collaborate on Developing Adjustable PC-IOLs

Alcon and RxSight willjointly develop adjustable presbyopia-correcting intraocular lenses (PC-IOLs) under a new nonexclusive agreement, the companies announced July 6. The collaboration aims to com...

7/10/2026
BiosimilarsBreakingRetina
Harrow Relaunches Lucentis Biosimilar Byooviz in the US
Harrow Relaunches Lucentis Biosimilar Byooviz in the US

Harrow announced July 1 that it had relaunched Byooviz (ranibizumab-nuna), a Lucentis biosimilar, in the US. The Nashville, Tennessee, company secured US rights to Byooviz and another ophthalmic bi...

7/10/2026
BreakingCataractDiagnosticFLACSIndustryRefractiveSurgical
LensCrafters Adds Refractive and Cataract Surgery Options to New Center
LensCrafters Adds Refractive and Cataract Surgery Options to New Center

LensCrafters, part of French company EssilorLuxottica, announced June 30 that it was launching the first LensCrafters Vision & Eye Health Center, addingsurgical procedures and advanced diagnostics ...

7/10/2026
BreakingRegulationThyroid Eye Disease
US FDA Accepts sBLA for Genentech Subcutaneous TED Candidate, Grants Priority Review
US FDA Accepts sBLA for Genentech Subcutaneous TED Candidate, Grants Priority Review

Genentech announced June 30 that the US FDA had accepted its supplemental biologics license application (sBLA) for subcutaneous Enspryng (satralizumab) in thyroid eye disease (TED). The agency gran...

7/10/2026
BreakingCataractIOLPremiumStudySurgical
Global Team of Ophthalmologists Creates Questionnaire for Reporting Dysphotopsias
Global Team of Ophthalmologists Creates Questionnaire for Reporting Dysphotopsias

Twenty multinational ophthalmic specialists, including key opinion leaders, have developed a consensus-based classification system and questionnaire for reporting dysphotopsias after ophthalmic pro...

7/10/2026
AIBreakingCataractDigitalSurgical
Bausch + Lomb Rolls Out Orphia Digital Platform, Initially Focused on Patient Education
Bausch + Lomb Rolls Out Orphia Digital Platform, Initially Focused on Patient Education

Bausch + Lomb reported July 9 the introduction of Orphia, a new AI-powered digital health platform intended to increase eye care providers’ efficiency. It will initially provide pre-surgery catarac...

7/10/2026
BreakingDry EyeStudy
Researchers Develop Dry Eye Candidate Powered by Spinach and Light
Researchers Develop Dry Eye Candidate Powered by Spinach and Light

Researchers in Singapore have developed a spinach-derived nanotechnology that enables corneal cells to produce a key antioxidant molecule when exposed to ambient light. The team at the National Uni...

7/10/2026
BreakingCataractIndiaSurgical
HelpMeSee Accelerates MSICS Training in India with New Center in Guwahati
HelpMeSee Accelerates MSICS Training in India with New Center in Guwahati

Global nonprofit group HelpMeSee and its Indian subsidiary, HMS Vision Private Limited, have launched virtual training for manual small incision cataract surgery (MSICS) in Guwahati, India. Trainin...

Provider Surveys & Interviews

Grab a seat at the table and join the thousands of ophthalmologists and optometrists from over 60 countries who are helping shape the next generation of diagnostics, pharmaceuticals, devices, and equipment by sharing your opinion and experience. Make your voice heard!
Table of Innovation

Choose Your Own Adventure

Participation options include weekly polls, special sponsored surveys, syndicated quarterly surveys, focus groups, and interviews, each with varying levels of honoraria.

Safe, Secure & On Any Device

We follow all industry standards to ensure confidentiality between participants and clients. Start and stop surveys anytime on our free Market Scope+ App or on desktop, each with a personalized dashboard just for you.

Pre-Qualified Invitations

We individually verify all potential participants before each survey or interview, ensuring that only licensed eye care professionals are invited and they are never kicked out or disqualified.

Better Data = Better Decisions

A team of industry experts and analysts review each data point, so you can be confident in the results and trends provided in our reports.

Market Scope+ App Screen

Market Scope Methodology

A Multi-Step Approach for Accurate & Timely Data

Proprietary data

  • 20+ years of physician survey data
  • Disease models
  • Cultivated database of physicians, ASCs, and hospitals
  • Insight from our team of in-house industry experts

Public data

  • Attendance and participation at major, worldwide meetings
  • Public health systems and registries
  • Clinical study data
  • Analysis of company-published financial reports

Join Market Scope Today

Register A Corporate Account

A corporate account gives you access to licensed reports and subscriptions, the latest news, a personalized dashboard, and weekly emails with news and data.

Select one or more
Select one or more

Register A Clinical Account

A clinical account gives you access to survey participation and results, weekly polls, benchmark reports, a searchable news archive, and more on a personalized dashboard.

Select your country...